Novartis Pharma B.V.

Location

Noord-Holland

Founded

1948-02-10

Risk Signals

21161 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about Novartis Pharma B.V.

Live alerts from global media, monitored by Business Radar

TIBAX - Thornburg Investment Income Builder Fund - Discloses $184.08K Position in Novartis (SIX:NOVN)

2023-08-26 (nasdaq.com)

TIBAX - Thornburg Investment Income Builder Fund - Discloses $184.08K Position in Novartis (SIX:NOVN)

Fintel reports that TIBAX - Thornburg Investment Income Builder Fund - has filed a NP with the SEC disclosing ownership of 1,830.71K shares of Novartis AG (SIX:NOVN) valued at $184.08K.

Read more
TIBAX - Thornburg Investment Income Builder Fund - Discloses $184.08K Position in Novartis (SIX:NOVN)

2023-08-26 (nasdaq.com)

TIBAX - Thornburg Investment Income Builder Fund - Discloses $184.08K Position in Novartis (SIX:NOVN)

Fintel reports that TIBAX - Thornburg Investment Income Builder Fund - has filed a NP with the SEC disclosing ownership of 1,830.71K shares of Novartis AG (SIX:NOVN) valued at $184.08K.

Read more
J&J, Novartis help Medicxi raise €400M biopharma fund

2019-07-18 (fiercebiotech.com)

J&J, Novartis help Medicxi raise €400M biopharma fund

Medicxi has raised a €400 million ($448 million) biopharma investment fund. | Medicxi has raised a €400 million ($448 million) biopharma investment fund. Johnson & Johnson and Novartis pumped money into the fund as cornerstone strategic investors, helping Medicxi wrap up fundraising in record time.

Read more
J&J, Novartis help Medicxi raise €400M biopharma fund

2019-07-18 (fiercebiotech.com)

J&J, Novartis help Medicxi raise €400M biopharma fund

Medicxi has raised a €400 million ($448 million) biopharma investment fund. | Medicxi has raised a €400 million ($448 million) biopharma investment fund. Johnson & Johnson and Novartis pumped money into the fund as cornerstone strategic investors, helping Medicxi wrap up fundraising in record time.

Read more

Never miss a headline about Novartis Pharma B.V.

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages